MRC1 and stroke disorder: Thus, it is possible that IFNAR1 signaling induces STAT3 activation, leading to the suppression of tPA-enhanced inflammatory molecules, IL-1α, IL-1β and CD86, expression and the promotion of anti-inflammatory molecules, Arg1 and CD206, upregulation in MG in delayed tPA-treated stroke animals.